Search - tctmd.com

Displaying 81 - 100 of 270

Sort: Relevancy | Date

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Presentation TCT 2023

TCT 163: Artificial Intelligence-Enabled Assessment of Right Ventricular to Pulmonary Artery Coupling Refines Mortality Prediction in Patients with Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Presenter: Mark Lachmann

October 26, 2023

Presentation TCT 2023

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

Presenter: Suzanne Arnold

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

TCT 233: One-year outcomes after CE-marked approved bicaval-valve system implantation in patients with severe tricuspid regurgitation.

Presenter: Ignacio Amat-Santos

October 26, 2023

Presentation TCT 2023

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

Presenter: Rodrigo Estevez-Loureiro

October 26, 2023

Presentation TCT 2023

TCT 845: BICAVAL VALVE IMPLANTATION FOR SEVERE TRICUSPID REGURGITATION IN A NONAGENARIAN PATIENT - ONE YEAR FOLLOW UP

Presenter: Edgar Lamas

October 26, 2023

Presentation TCT 2023

TCT 295: Race and Ethnicity in Patients With Severe Tricuspid Regurgitation: An Exploration of Disparities

Presenter: Julio Echarte- Morales

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

Caitlin E. Cox

July 21, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

Advertisement

Top Structural Heart News of 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

TCT 163: Artificial Intelligence-Enabled Assessment of Right Ventricular to Pulmonary Artery Coupling Refines Mortality Prediction in Patients with Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

TCT 233: One-year outcomes after CE-marked approved bicaval-valve system implantation in patients with severe tricuspid regurgitation.

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

TCT 845: BICAVAL VALVE IMPLANTATION FOR SEVERE TRICUSPID REGURGITATION IN A NONAGENARIAN PATIENT - ONE YEAR FOLLOW UP

TCT 295: Race and Ethnicity in Patients With Severe Tricuspid Regurgitation: An Exploration of Disparities

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

What’s Going to Be Hot at TCT 2023

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content